| [1] |
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768.
|
| [2] |
YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang.
Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806.
|
| [3] |
ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang.
Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813.
|
| [4] |
ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang.
Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820.
|
| [5] |
DU Wei-xin, WEI Fen, LU Jin-biao, ZHAO Ai-hua, PU Jiang, WANG Guo-zhi, XU Miao.
Preliminary establishment of national reference of the freeze-dried recombinant Mycobacterium tuberculosis allergen for the bulk potency evaluation
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 826-831.
|
| [6] |
QU Meng-jin, LIANG Zheng-min, WANG Yuan-zhi, ZHOU Xiang-mei.
Research progress of carbohydrate metabolism of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 874-879.
|
| [7] |
SUN Qing, HUANG Hai-rong, WANG Gui-rong.
In vitro activities and drug resistance mechanisms of bedaquiline, clofazimine and delamanid against common pathogenic non-tuberculous mycobacteria
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 880-884.
|
| [8] |
SONG Yi-meng, LI Yuan-chun, HE Wen-cong, HE Ping, BAO Jing-jing, LIU Chun-fa, LIU Dong-xin, WANG Xin-yang, ZHAO Yan-lin, LI Yan-ming.
Cost analysis of fluorescence PCR probe melting curve technique for the detection of Mycobacterium tuberculosis resistance in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 712-717.
|
| [9] |
BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing.
Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724.
|
| [10] |
ZHANG Jie, REN Yi-xuan, PAN Li-ping, ZHANG Zong-de.
Application of whole genome sequencing in research of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 737-740.
|
| [11] |
MA Jin-bao, REN Fei, ZENG Ling-cheng, CHEN Ming-wei.
Analysis of drug susceptibility of 680 patients with multidrug-resistant tuberculosis in Xi’an City from 2015 to 2019
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 609-613.
|
| [12] |
QIN Zhong-hua, JING Ye, DU Yan-qing, SONG Xiao-mei, ZHANG Li-xia.
Spectrum and drug resistance analysis of 339 strains of nontuberculous mycobacterium isolated from clinical practice
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 630-633.
|
| [13] |
ZHANG Jing, CHEN Xi, WANG Bin, FU Lei, LU Yu, CHEN Xiao-you.
Establishment of modified propidium monoazide (PMAxx)-quantitative PCR assay and its application for identification of antituberculosis drug activity
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 472-480.
|
| [14] |
LI Xin-na, SHEN Xin-xin, WANG Rui-bai, DUAN Su-xia, ZHANG Rui-qing, WANG Rui-huan, BAI Xue-ding, FAN Guo-hao, WANG Jin-rong, GAO Yuan, CHEN Zi-wei, MA Xue-jun.
Application value of probe-directed recombinase amplification assay in detecting MTB rpoB gene mutation
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 481-488.
|
| [15] |
ZHOU Yin-fa,ZHANG Shan-ying,DAI Zhi-song,CHEN Dai-quan,LI Wei-lin,ZHAO Yong,LIN Shu-fang.
Prevalence and influencing factors of rifampicin resistance among high-risk group of drug-resistant tuberculosis in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 339-344.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
